Toorop AA, van Kempen ZLE, Steenhuis M, Nielsen J, et al. Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2023 Jan 13:jnnp-2022-330467.
PMID: 36639226